Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

35.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.0K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

525
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
525
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.0K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.0K
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

486
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
486
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

419
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
419
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

817
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
817

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics.

Journal of proteome research·2026
Same author

A Streamlined Synthesis of Adenosine Vinylsulfonamide Probes for Aminoacyl-AMP Mimicry in NRPS.

Chembiochem : a European journal of chemical biology·2026
Same author

Identification of ovarian cancer-associated antigens forming complexes with autoantibodies.

Journal of ovarian research·2026
Same author

Immunohistochemical detection of teleost- and mammalian-type melanin-concentrating hormone in goldfish brain with newly developed specific antibodies.

General and comparative endocrinology·2025
Same author

Structure-Activity Relationship of an All-α-helical Prenyltransferase Reveals the Mechanism of Indole Prenylation.

Biochemistry·2025
Same author

Latest Trend of Endovascular Treatment for Lower Extremity Artery Disease and Recommendations from Interventional Radiologist: To Continue Engaging in This Field Moving Forward.

Interventional radiology (Higashimatsuyama-shi (Japan)·2025

Related Experiment Video

Updated: Nov 18, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.2K

Circulating prorenin: its molecular forms and plasma concentrations.

Kazumi Fujimoto1,2, Sayuki Kawamura1, Satoru Bando1

  • 1Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan.

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|February 10, 2021
PubMed
Summary
This summary is machine-generated.

Researchers identified novel molecular forms of human plasma prorenin, revealing concentrations significantly higher than previously reported. This finding advances understanding of the renin-angiotensin-aldosterone system in health and disease.

Keywords:
ELISAPlasma binding proteinPlasma concentrationPlasma molecular formProrenin

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.2K
Transcutaneous Assessment of Renal Function in Conscious Rodents
07:18

Transcutaneous Assessment of Renal Function in Conscious Rodents

Published on: March 26, 2016

12.7K

Related Experiment Videos

Last Updated: Nov 18, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.2K
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.2K
Transcutaneous Assessment of Renal Function in Conscious Rodents
07:18

Transcutaneous Assessment of Renal Function in Conscious Rodents

Published on: March 26, 2016

12.7K

Area of Science:

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Background:

  • The renin-angiotensin-aldosterone system is crucial for fluid balance and disease pathogenesis.
  • Understanding plasma prorenin's molecular forms and accurate measurement is clinically significant but currently limited.

Purpose of the Study:

  • To elucidate the molecular forms of human plasma prorenin.
  • To develop a method for directly measuring plasma prorenin concentration without conversion to renin.

Main Methods:

  • Polyacrylamide gel electrophoresis and immunoblotting with prosegment-specific antibodies were used to analyze molecular forms.
  • A sandwich enzyme-linked immunosorbent assay (ELISA) was developed for direct quantification.

Main Results:

  • Identified three major plasma prorenin components: a modified full-length protein, an albumin-bound form, and a truncated form.
  • Established normal plasma prorenin levels in healthy individuals as 3.0-13.4 μg/mL, orders of magnitude higher than previously reported.
  • Plasma prorenin concentration remained stable regardless of donor posture, unlike plasma renin activity.

Conclusions:

  • Human plasma prorenin exists in multiple molecular forms, including modified, albumin-bound, and truncated variants.
  • Plasma prorenin concentrations are substantially higher than previously estimated.
  • These findings offer new insights into prorenin's role in homeostasis and disease, paving the way for clinical assays.